症状性颈动脉狭窄行颈动脉内膜切除术后两年死亡风险评分
基于血管质量倡议(Vascular Quality Initiative)颈动脉内膜切除术(CEA)模块中24,713例症状性颈动脉分叉狭窄手术,建立2年死亡风险评分,评分≤4分者2年死亡率<4%,≥17分者>35%,并在20,668例症状性颈动脉支架置入队列中验证,受试者工作特征曲线下面积0.70。
要点
- 风险评分纳入17项变量,包括改良Rankin评分(aOR 4.46)、终末期肾病透析(aOR 2.38)、贫血(aOR 2.09)等。
- 评分≤4分者2年死亡率<4%,评分≥17分者>35%,呈陡峭上升趋势。
- 验证队列中19个风险评分数据点有16个死亡率无统计学差异,受试者工作特征曲线下面积0.70。
核心结论
- 开发出能较准确判断症状性狭窄CEA术后2年生存的风险评分,有助于医患共同决策和预期咨询。
- 术前卒中严重程度、透析状态、基线贫血、高龄、低体重和心肺合并症是对生存影响最大的不利变量。
研究设计与样本
- 回顾性查询血管质量倡议CEA模块中因症状性(180天内)颈动脉分叉狭窄行CEA的病例,排除后24,713例纳入研究。
- 采用χ2检验和Student t检验进行单变量分析,多变量二元逻辑回归纳入单变量显著(P<.05)变量,多变量P≤.05的变量进入风险评分。
- 风险评分在血管质量倡议中20,668例因症状性疾病行颈动脉支架置入且手术风险可接受的患者中验证。
主要发现
- 风险评分纳入变量及调整比值比(aOR):居住地处于区域剥夺指数前20%(最弱势)aOR 1.20;女性aOR 1.157;体重指数<20 kg/m2 aOR 1.49;任何吸烟史aOR 1.39;冠心病aOR 1.47;充血性心力衰竭史aOR 1.47;慢性阻塞性肺疾病aOR 1.45;基线肾功能不全aOR 1.46;就诊时终末期肾病透析状态aOR 2.38;美国麻醉医师学会4级手术风险aOR 1.33;糖尿病aOR 1.16;贫血aOR 2.09;外周动脉介入史aOR 1.20;主要下肢截肢史aOR 1.93;既往CEA或颈动脉支架置入aOR 1.32;术前改良Rankin评分递增aOR 4.46;年龄递增aOR 1.04/年。
- 风险评分≤4分者2年死亡率<4%,评分≥17分者>35%,呈陡峭上升。
- 多变量回归Hosmer-Lemeshow拟合优度检验总体准确率93.1%,预测生存准确率99.9%。
- 症状性颈动脉支架置入队列验证中,19个风险评分数据点有16个死亡率无统计学差异,随评分升高死亡率上升模式几乎相同。
- 验证队列中风险评分受试者工作特征曲线下面积0.70,Hosmer-Lemeshow总体准确率91.3%。
临床怎么用
- 作者认为该评分可用于患者共同决策和预期咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study is to identify variables at the time of clinical presentation that place patients at higher risk for mortality following carotid endarterectomy (CEA) for symptomatic lesions. Further, this study will create a risk score for mortality within 2 years following CEA for symptomatic stenosis to help tailor future postoperative and long-term management by identifying patients who require heightened vigilance in postoperative care to facilitate survival. METHODS: The Vascular Quality Initiative CEA module was queried for procedures performed for symptomatic (within 180 days) carotid bifurcation stenosis. After exclusions, 24,713 met study inclusion. Univariable analysis for the binary outcome of mortality within 2 years of surgery was performed with χ2 testing for categorical variables and Student t-test for ordinal variables. Multivariable binary logistic regression was then performed utilizing variables that achieved univariable significance (P < .05) for the outcome. Variables with a multivariable P value ≤ .05 were included in the risk score and weighted based on their respective regression beta-coefficient in a point scale. Variables with a beta-coefficient of less than .25 were assigned 1 point, and then a point was added for each rise in beta-coefficient at .25 intervals. The risk score was then tested utilizing 20,668 patients deemed to be of acceptable surgical risk who underwent carotid stenting for symptomatic disease in the Vascular Quality Initiative. RESULTS: Variables that achieved multivariable significance (P<.05) towards the outcome of mortality within 2 years of symptomatic CEA that were included in the risk score were: home status within the top 20% of area deprivation index (most disadvantaged) (adjusted odds ratio [aOR], 1.20); female sex (aOR, 1.157); body mass index <20 kg/m2 (aOR, 1.49); any history of tobacco smoking (aOR, 1.39); coronary artery disease (aOR, 1.47); history of congestive heart failure (aOR, 1.47); chronic obstructive pulmonary disease (aOR, 1.45); baseline renal insufficiency (aOR, 1.46); end-stage renal disease dialysis status at presentation (aOR, 2.38); American Society of Anesthesiology class 4 operative risk designation (aOR, 1.33); diabetes mellitus (aOR, 1.16); anemia (aOR, 2.09); history of peripheral artery intervention (aOR, 1.20); history of major lower extremity amputation (aOR, 1.93); prior CEA or carotid stenting (aOR, 1.32); escalating preoperative modified Rankin score (aOR, 4.46); and escalating age (aOR, 1.04/year). A steep escalation was noted from 2-year mortality rates of <4% for patients with risk scores of ≤4 to >35% for patients with scores of ≥17. Hosmer and Lemeshow goodness of fit testing for the multivariable regression analysis revealed an overall accuracy of 93.1% for the model, with 99.9% accuracy in predicting survival. Model testing in the symptomatic carotid stenting cohort revealed excellent correlation with no statistical difference in the mortality rate at 16 of the 19 risk score data points and a near identical mortality escalation pattern with rising risk score. When applied to the validation cohort, the risk score had an area under the receiver operating characteristic curve of 0.70 and a Hosmer-Lemeshow overall accuracy of 91.3%. CONCLUSIONS: A risk score with quality accuracy in determining 2-year survival after CEA performed for symptomatic stenosis has been developed. Severity of preoperative stroke, dialysis status, baseline anemia, advancing age, low body weight, and cardiopulmonary comorbidities are the most deleterious variables negatively impacting survival. The score has utility in patient shared decision-making and expectation counseling.
引用
- Blecha M, Weise L, Liu A, et al. Risk score for two-year mortality following carotid endarterectomy performed for symptomatic stenosis. J Vasc Surg. 2024. PMID: 39725245. doi:10.1016/j.jvs.2024.12.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。